These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16100492)

  • 1. Focal nodular hyperplasia (FNH): a potential cause of false-positive positron emission tomography.
    Aznar DL; Ojeda R; Garcia EU; Aparici F; Sánchez PA; Flores D; Martínez C; Sopena R
    Clin Nucl Med; 2005 Sep; 30(9):636-7. PubMed ID: 16100492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver.
    Kurtaran A; Becherer A; Pfeffel F; Müller C; Traub T; Schmaljohann J; Kaserer K; Raderer M; Schima W; Dudczak R; Kletter K; Virgolini I
    Liver; 2000 Dec; 20(6):487-90. PubMed ID: 11169064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
    Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F
    Clin Nucl Med; 2009 Oct; 34(10):659-65. PubMed ID: 19893396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG.
    Shiomi S; Kurooka H; Iwata Y; Sasaki N; Masaki K; Jomura H; Nishiguchi S; Kuroki T; Ochi H
    Ann Nucl Med; 1999 Dec; 13(6):427-31. PubMed ID: 10656279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
    Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
    Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia.
    Bertagna F; Orlando E; Bosio G; Bercich L; Fisogni S; Grazioli L; Giubbini R
    Clin Nucl Med; 2011 Apr; 36(4):305-8. PubMed ID: 21368608
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
    Iwata Y; Shiomi S; Sasaki N; Jomura H; Nishiguchi S; Seki S; Kawabe J; Ochi H
    Ann Nucl Med; 2000 Apr; 14(2):121-6. PubMed ID: 10830530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.
    van den Esschert JW; Bieze M; Beuers UH; van Gulik TM; Bennink RJ
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):436-40. PubMed ID: 20717825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
    Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
    J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma.
    Huo L; Wu Z; Zhuang H; Fu Z; Dang Y
    Clin Nucl Med; 2009 Dec; 34(12):874-7. PubMed ID: 20139820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
    Ho CL; Yu SC; Yeung DW
    J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography-A parametric analysis.
    Hsu YL; Chen YW; Lin CY; Lai YC; Chen SC; Lin ZY
    Kaohsiung J Med Sci; 2015 Dec; 31(12):621-5. PubMed ID: 26709223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early dynamic F18-FDG-PET shows a hypervascular pattern with central scar in a liver mass.
    Schierz JH; Lopatta E; Settmacher U; Freesmeyer M
    Liver Int; 2012 Oct; 32(9):1372. PubMed ID: 22882619
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
    van den Esschert JW; van Gulik TM; Phoa SS
    Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation.
    Ji Y; Zhu X; Sun H; Tan Y; Ma Z; Ye Q; Sujie A; Tang Z
    Chin Med J (Engl); 2000 Sep; 113(9):852-7. PubMed ID: 11776086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
    Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
    BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
    Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of benign vs malignant hepatic lesions with positron emission tomography.
    Delbeke D; Martin WH; Sandler MP; Chapman WC; Wright JK; Pinson CW
    Arch Surg; 1998 May; 133(5):510-5; discussion 515-6. PubMed ID: 9605913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.
    Lim D; Lee SY; Lim KH; Chan CY
    World J Gastroenterol; 2013 Jul; 19(27):4432-6. PubMed ID: 23885159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.